Sequenom Eyes 25K T21 Tests Billed in 2012 | GenomeWeb

By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – Sequenom officials today said that the firm's Center for Molecular Medicine has billed for more than 1,000 MaterniT21 tests since its launch in mid-October, and Chairman and CEO Harry Hixson said the firm's goal is to bill 25,000 T21 tests in 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.